206 related articles for article (PubMed ID: 29214213)
1. Therapeutic Potential of Arsenic Trioxide (ATO) in Treatment of Hepatocellular Carcinoma: Role of Oxidative Stress in ATO-Induced Apoptosis.
Dugo EB; Yedjou CG; Stevens JJ; Tchounwou PB
Ann Clin Pathol; 2017; 5(1):. PubMed ID: 29214213
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Arsenic Trioxide Potential for Lung Cancer Treatment: Assessment of Apoptotic Mechanisms and Oxidative Damage.
Walker AM; Stevens JJ; Ndebele K; Tchounwou PB
J Cancer Sci Ther; 2016 Jan; 8(1):1-9. PubMed ID: 27158419
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D3 potentiates the antitumorigenic effects of arsenic trioxide in human leukemia (HL-60) cells.
Rogers CS; Yedjou CG; Sutton DJ; Tchounwou PB
Exp Hematol Oncol; 2014 Mar; 3(1):9. PubMed ID: 24661615
[TBL] [Abstract][Full Text] [Related]
4. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
Liu ZM; Tseng JT; Hong DY; Huang HS
Biochem J; 2011 Sep; 438(2):349-58. PubMed ID: 21649584
[TBL] [Abstract][Full Text] [Related]
5. Arsenic Trioxide Induces Apoptosis via Specific Signaling Pathways in HT-29 Colon Cancer Cells.
Stevens JJ; Graham B; Dugo E; Berhaneselassie-Sumner B; Ndebele K; Tchounwou PB
J Cancer Sci Ther; 2017 Jan; 9(1):298-306. PubMed ID: 28966729
[TBL] [Abstract][Full Text] [Related]
6. Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinoma in vitro and in vivo.
Song J; Zhao Z; Fan X; Chen M; Cheng X; Zhang D; Wu F; Ying X; Ji J
Oncotarget; 2016 Oct; 7(43):70504-70515. PubMed ID: 27655700
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation.
Zhai B; Jiang X; He C; Zhao D; Ma L; Xu L; Jiang H; Sun X
Tumour Biol; 2015 Apr; 36(4):2323-34. PubMed ID: 25416439
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
Lam HK; Li K; Chik KW; Yang M; Liu VC; Li CK; Fok TF; Ng PC; Shing MM; Chuen CK; Yuen PM
Int J Oncol; 2005 Aug; 27(2):537-45. PubMed ID: 16010437
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.
Cui L; Gao B; Cao Z; Chen X; Zhang S; Zhang W
Mol Med Rep; 2016 Mar; 13(3):2032-8. PubMed ID: 26781180
[TBL] [Abstract][Full Text] [Related]
10. OXIDATIVE STRESS IN HUMAN LEUKEMIA (HL-60), HUMAN LIVER CARCINOMA (HepG2), AND HUMAN (JURKAT-T) CELLS EXPOSED TO ARSENIC TRIOXIDE.
Yedjou CG; Tchounwou PB
Met Ions Biol Med; 2006; 9():298-303. PubMed ID: 26435679
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the cellular effects and mechanism of arsenic trioxide-induced hepatotoxicity in broiler chickens.
Wang C; Ning Z; Wan F; Huang R; Chao L; Kang Z; Yang F; Zhong G; Li Y; Pan J; Tang Z; Hu L
Toxicol In Vitro; 2019 Dec; 61():104629. PubMed ID: 31442540
[TBL] [Abstract][Full Text] [Related]
12. Salvianolic Acid A Protects H9c2 Cells from Arsenic Trioxide-Induced Injury via Inhibition of the MAPK Signaling Pathway.
Zhang JY; Sun GB; Luo Y; Wang M; Wang W; Du YY; Yu YL; Sun XB
Cell Physiol Biochem; 2017; 41(5):1957-1969. PubMed ID: 28391263
[TBL] [Abstract][Full Text] [Related]
13. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
Li W; Wang M; Wang L; Ji S; Zhang J; Zhang C
Cell Biochem Biophys; 2014 Mar; 68(2):427-36. PubMed ID: 23975599
[TBL] [Abstract][Full Text] [Related]
14. The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.
Luo Q; Li Y; Lai Y; Zhang Z
J Toxicol Sci; 2015 Jun; 40(3):349-63. PubMed ID: 25972196
[TBL] [Abstract][Full Text] [Related]
15. Effect of arsenic trioxide (ATO) on human lung carcinoma PG cell line: ATO induced apoptosis of PG cells and decreased expression of Bcl-2, Pgp.
Han B; Zhou G; Zhang Q; Zhang J; Wang X; Tang W; Kakudo K
J Exp Ther Oncol; 2004 Dec; 4(4):335-42. PubMed ID: 15844663
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
[TBL] [Abstract][Full Text] [Related]
17. Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation.
Calviño E; Estañ MC; Simón GP; Sancho P; Boyano-Adánez Mdel C; de Blas E; Bréard J; Aller P
Biochem Pharmacol; 2011 Dec; 82(11):1619-29. PubMed ID: 21889928
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma.
Zhang X; Yang XR; Sun C; Hu B; Sun YF; Huang XW; Wang Z; He YF; Zeng HY; Qiu SJ; Cao Y; Fan J; Zhou J
Cancer Lett; 2015 Sep; 366(1):112-22. PubMed ID: 26118777
[TBL] [Abstract][Full Text] [Related]
19. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide.
Chien CW; Yao JH; Chang SY; Lee PC; Lee TC
Toxicol Appl Pharmacol; 2011 Nov; 257(1):59-66. PubMed ID: 21889949
[TBL] [Abstract][Full Text] [Related]
20. PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.
Luo Q; Li Y; Deng J; Zhang Z
Chem Biol Interact; 2015 Jan; 226():12-22. PubMed ID: 25499136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
